Singapore markets open in 2 hours 2 minutes
Straits Times Index
3,292.69 +10.64 (+0.32%) S&P 500
5,018.39 -17.30 (-0.34%) Dow
37,903.29 +87.37 (+0.23%) Nasdaq
15,605.48 -52.34 (-0.33%) Bitcoin USD
57,886.71 -2,592.17 (-4.29%) CMC Crypto 200
1,273.53 -65.54 (-4.90%)
Eupraxia Pharmaceuticals Inc. (EPRX.TO)
Toronto - Toronto Real-time price. Currency in CAD
Add to watchlist
At close: 03:56PM EDT
Currency in CAD
Valuation measures4
| Market cap (intra-day) | 131.45M |
| Enterprise value | 122.56M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 59.31 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -4.44 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.13 |
| 52-week change 3 | -39.51% |
| S&P500 52-week change 3 | 23.10% |
| 52-week high 3 | 9.1000 |
| 52-week low 3 | 3.4400 |
| 50-day moving average 3 | 4.7460 |
| 200-day moving average 3 | 6.1046 |
Share statistics
| Avg vol (3-month) 3 | 68.94k |
| Avg vol (10-day) 3 | 42.74k |
| Shares outstanding 5 | 35.62M |
| Implied shares outstanding 6 | 35.62M |
| Float 8 | 29.91M |
| % held by insiders 1 | 6.70% |
| % held by institutions 1 | 4.04% |
| Shares short (15 Apr 2024) 4 | 800 |
| Short ratio (15 Apr 2024) 4 | 0.01 |
| Short % of float (15 Apr 2024) 4 | 0.00% |
| Short % of shares outstanding (15 Apr 2024) 4 | 0.00% |
| Shares short (prior month 15 Mar 2024) 4 | 101.37k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in USD.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -88.37% |
| Return on equity (ttm) | -715.19% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -27.73M |
| Net income avi to common (ttm) | -28.22M |
| Diluted EPS (ttm) | -1.1700 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 19.34M |
| Total cash per share (mrq) | 0.54 |
| Total debt (mrq) | 10.45M |
| Total debt/equity (mrq) | 1,171.32% |
| Current ratio (mrq) | 1.02 |
| Book value per share (mrq) | 0.08 |
Cash flow statement
| Operating cash flow (ttm) | -20.68M |
| Levered free cash flow (ttm) | -10.78M |
© 2024 Yahoo. All rights reserved.